Navigation Links
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Date:7/18/2014

rice of AbbVie shares or Shire shares, significant transaction costs and/or unknown liabilities, general economic and business conditions that affect the combined companies following the consummation of the possible combination, changes in global, political, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax laws, regulations, rates and policies, future business combinations or disposals and competitive developments. These forward-looking statements are based on numerous assumptions and assessments made in light of AbbVie's or, as the case may be, Shire's experience and perception of historical trends, current conditions, business strategies, operating environment, future developments and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this announcement could cause AbbVie's plans with respect to Shire, AbbVie's or Shire's actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and persons reading this announcement are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this announcement. Additional information about economic, competitive, governmental, technological and other factors that may affect AbbVie is set forth in Item 1A, "Risk Factors," in AbbVie's 2013 Annual Report on Form 10-K, which has been filed with the SEC, the contents of which are not incorporated by reference into, nor do they
'/>"/>
SOURCE AbbVie Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
2. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
3. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
4. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
5. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
6. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
7. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
8. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
9. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
10. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
11. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 The nuclear ... by 2020 at a CAGR of 12.08%. Nuclear medicine ... diseases. The two major types of Nuclear imaging used ... was the mainstream modality for nuclear medicine applications like ... to change because of global shortage of molybdenum-99 isotope ...
(Date:6/1/2015)... About Pressure Relief Devices ... and improve the quality life of patients who suffer ... a significant role in inhibiting the growth and treatment ... turn or rotate an immobile patient by providing all ... and specialty beds. These devices have the ability to ...
(Date:6/1/2015)... June 1, 2015 Select Medical Holdings Corporation ... Corporation, a joint venture that Select Medical Corporation ("Select") ... completed its previously announced acquisition of Concentra Inc.  Cressey ... venture. About Select Medical Corporation ... hospitals and outpatient rehabilitation clinics in the ...
Breaking Medicine Technology:North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 3Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Nov. 3 WebMD Health Corp. (Nasdaq: WBMD ) announced ... to purchase up to 5,700,000 shares of its common stock at ... price per share of WebMD,s common stock on the Nasdaq Global ... The number of shares proposed to be purchased in the tender ...
... , SAN DIEGO, Nov. 3 Robert Mazzacavallo has ... Diego-based Veridiam is a contract manufacturer of high-precision, fabricated ... in the medical devices, power generation, aerospace and general ... Financial Officer at C-Tech Industries in Camas, WA. ...
Cached Medicine Technology:WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock 2WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock 3Veridiam Names Robert Mazzacavallo New CFO 2
(Date:6/1/2015)... 01, 2015 There’s never a good time ... comes to non-emergency, minor illnesses. , As of June 1, ... access to medical care via the Internet. Patients throughout Illinois ... or computer. , “Everyone is busy. We know that getting ... so we want to make it easier,” said Jeffry Tillery, ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Listen to ... established automotive companies are using more granular data to ... two comparatively new industry voices in Josep Celaya Gonzalez, ... winning start-up ParkTAG. As an automotive insurer, MAPFRE are ... as an easy-to-use solution to the driver. Award winning ...
(Date:6/1/2015)... InstantLabs will co-develop and commercialize a ... a Cooperative Research and Development Agreement (CRADA) with the ... with U.S. Farm Bill legislation, only members of the ... the United States. , InstantLabs’ DNA-based technology will ... need rather than requiring samples be sent to centralized ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 This is ... Annual GrowRIVERSIDE Conference: The Future of Local Food, June ... conference will assist cities in examining and ... urban agriculture infrastructure. , Organized for the city of ... feature a broad lineup of speakers ranging from urban ...
(Date:6/1/2015)... Strategic Radiology (SR) announced today that Rome Radiology ... the SR coalition of progressive, independent radiology groups geographically ... now have access to collective resources in all aspects ... deployment of subspecialized radiology services. With the addition of ... US based radiology group practices. , “We are ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 3Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 4Health News:Limited Tickets Available for “GrowRIVERSIDE” Conference June 11 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 4
... 4th Leading Cause of Death in U.S., SWANTON, ... Awareness Month, to help raise awareness about Chronic,Obstructive Pulmonary ... AllerAir will be making downloadable,tips available to COPD patients ... their November newsletter and blogs to raising awareness,about this ...
... TORONTO, Nov. 3 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc.,a ... cancer therapies, announced today that Dr. Alan M.,Ezrin, ... will present a,corporate update at Rodman & Renshaw ... New York City from November 10th - 12th ...
... /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. (TSX: PMD; PREMF.pk) ... Exchange ("TSX") that it is reviewing the eligibility of ... The Company is being reviewed under the TSX,s ... comply with all requirements for continued,listing. If the Company ...
... cash flow from operations, updated guidance, and new stock ... ... (Nasdaq: AMCS ), a,leader in radiology and medical image and ... ended,September 30, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ...
... out than those without deployed kin , , MONDAY, Nov. 3 ... Iraq and Afghanistan are more likely to have behavioral problems ... , Researchers studied 169 families with children aged 18 months ... at a Marine base. , Of those families, 55 (33 ...
... Cox-1 drugs, like naproxen, study says , , MONDAY, Nov. ... attack that comes with the use of nonsteroidal anti-inflammatory ... to the specific pain-causing molecule they act against, a ... between the degree of inhibition in vitro [in the ...
Cached Medicine News:Health News:AllerAir Dedicates November to COPD Awareness Month 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 3Health News:Listing Review initiated by the Toronto Stock Exchange 2Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 2Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 3Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 4Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 5Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 6Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 7Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 8Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 9Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 10Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 11Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 12Health News:Kids With Parent in War Zone Face Behavior Risks 2Health News:Study Sheds Light on Painkillers' Heart Risk 2Health News:Study Sheds Light on Painkillers' Heart Risk 3